Table 2 CMR parameters among OCAD patients with and without MetS and controls
Controls (n = 52) | OCAD(MetS−) (n = 38) | OCAD(MetS+) (n = 83) | P value | |
|---|---|---|---|---|
Function parameters | ||||
LVEDV (mL) | 120.19 (105.81–138.65) | 142.85 (118.10–212.32)* | 176.42 (145.77–263.82)* | < 0.001 |
LVESV (mL) | 39.64 (33.01–48.81) | 60.38 (42.79–152.79)* | 93.12 (53.35–192.49)* | < 0.001 |
LVSV (mL) | \(81.48\pm 17.78\) | \(73.22\pm 17.17\) | \(78.23\pm 23.87\) | 0.181 |
LVEF (%) | 66.02 (63.05–70.42) | 56.12 (30.43–64.64)* | 45.27 (27.07–61.97)* | < 0.001 |
LVM (g) | 70.06 (60.96–83.23) | 94.73 (81.55–117.94)* | 123.79 (101.53–147.21)*# | < 0.001 |
LVGFI | 53.99 \(\pm\) 7.94 | 37.14 \(\pm 16.51\)* | 30.99 \(\pm 13.16\)*# | < 0.001 |
LV strain parameters | ||||
GRPS (%) | 37.18 (34.02–42.66) | 24.76 (11.93–31.98)* | 17.85 (9.65–28.09)* | < 0.001 |
GCPS (%) | − 20.59 (19.10–22.48) | − 17.46 (9.47–20.78)* | − 12.93 (7.88–17.83)* | < 0.001 |
GLPS (%) | − 15.53 (12.38–17.07) | − 10.63 (4.98–13.57)* | − 6.49 (3.77–10.70)*# | < 0.001 |
LGE pattern | OCAD(MetS−) (n = 36) | OCAD(MetS+) (n = 76) | ||
|---|---|---|---|---|
None, n (%) | – | 23 (63.9%) | 40 (52.6%) | 0.262 |
Subendocardial, n (%) | – | 7 (19.4%) | 18 (23.7%) | 0.615 |
Midmyocardium, n (%) | – | 2 (5.6%) | 11 (14.5%) | 0.289 |
Subepicardial, n (%) | – | 1 (2.8%) | 1 (1.3%) | 1.000 |
Transmural, n (%) | – | 3 (8.3%) | 6 (7.9%) | 1.000 |